![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C12Q 1/6886 | (2018.01) |
C12Q 1/6886 | (2013.01) | ||
C12Q2600/118 | (2013.01) | ||
C12Q2600/156 | (2013.01) |
(11) | Patento numeris | 3788173 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 19724365.2 |
Europos patento paraiškos padavimo data | 2019-05-03 | |
(97) | Europos patento paraiškos paskelbimo data | 2021-03-10 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-29 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/EP2019/061328 |
Data | 2019-05-03 |
(87) | Numeris | WO 2019/211418 |
Data | 2019-11-07 |
(30) | Numeris | Data | Šalis |
201862666329 P | 2018-05-03 | US |
(72) |
BALASUBRAMANYAM, Aarthi , US
JU, Christine , US
MA, Xiaoju , US
MULEY, Thomas , DE
HERTH, Felix , DE
TIKOO, Nalin , US
WEHNL, Birgit , DE
XI, Liu , US
YAUNG, Stephanie J. , US
PATI, Amrita , US
|
(73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
Roche Diagnostics GmbH , Sandhofer Straße 116, 68305 Mannheim, DE |
(54) | SURROGATE MARKER AND METHOD FOR TUMOR MUTATION BURDEN MEASUREMENT |
SURROGATE MARKER AND METHOD FOR TUMOR MUTATION BURDEN MEASUREMENT |